focus -WSS

focus

author：hotspot 2025-10-01 17:35:13 - browse：12363

Adobe

A month after announcing it was seeking strategic alternatives, Akili Interactive, maker of a video game designed to treat ADHD, said it will go private in a merger with Virtual Therapeutics. The deal is expected to net Akili’s shareholders $34 million.

Akili made headlines in 2020 when it received Food and Drug Administration clearance for EndeavorRx, a video game designed to treat pediatric ADHD. Akili went public in 2022 in a deal that valued the company at about $1 billion. But despite several strategic pivots, including shifting to direct-to-consumer sales, the company failed to build a sustainable business model. Akili in April announced it would wind down its existing commercial operations and focus on a licensing deal with Japanese pharma company Shionogi while it figured out the best path forward.

Akili is just one of many health tech companies that are struggling following an explosion of investor interest in digital health during the Covid-19 pandemic. In the last month alone, Better Therapeutics, another company making digital treatments, sold its assets for an undisclosed amount after failing to build a business around its app for type 2 diabetes, and Cue Health, a diagnostics startup, shut down after funding interest in its Covid-19 tests evaporated.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： Kellogg’s is going to war over Mexico’s nutrition label rules

knowledge

WSS

Vivek Ramaswamy made waves in the debate, much as in biotech

Pumping milk in bathrooms at health conferences is common

FDA endorses new sterilization method for medical devices

Head of FDA's diagnostics center, who led through Covid, retires

California store owner shot dead in dispute over displaying Pride flag: Police

CDC says it’s too soon to assess risk posed by Covid subvariant

leisure time

focus

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

focus

Bright Health sells Medicare Advantage business to Molina

Immunocompromised patients offer clues on chronic Covid

George Santos makes 1st court appearance after pleading not guilty to 13 counts

The inclusion problem at the heart of rehabilitation research

Tori Bowie and the unacceptable rates of Black maternal death

Kellogg’s is going to war over Mexico’s nutrition label rules

Novavax promises a turnaround & Lilly roils the obesity market

Intellia plays down concerns on accidental germline transmission

Psychedelics group wrestles with new pharma identity

HPV vaccine, cervical cancer study delivers historic results

explore

Trump to be booked at notorious Fulton County Jail at center of DOJ probe

How to make over

Cardiologists urge adding sexual orientation, gender identity to health records

FDA sets aggressive timeline for overhauling inspection procedures

Immunocompromised patients offer clues on chronic Covid

Printout prescription drug information shouldn’t go digital

knowledge

explore

leisure time

focus